Latest
Obesity drug tirzepatide significantly reduces the risk of infections and serious cardiovascular events
Tirzepatide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes and obesity, can reduce the risk of heart attacks and hospitalizations due to infections by about one-third…
Popular
Biomedical Advances
Obesity drug tirzepatide significantly reduces the risk of infections and serious cardiovascular events
Tirzepatide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes and obesity, can reduce the risk of heart attacks and hospitalizations due to infections by about one-third…
Diet and Lifestyle
Protein restriction: Reducing protein intake could promote healthy aging
A review of more than 350 studies suggests that protein restriction may promote healthy aging by improving metabolism, reducing cellular damage, and preserving cell function. …
Preventive Medicine
Boosting potassium intake: A new strategy for controlling hypertension
A new report suggests that effectively managing hypertension requires a combined strategy of increasing potassium intake while reducing sodium, prompting a shift in public health recommendations. …
